TY  - JOUR
AU  - Tenorio-Jiménez, Carmen
AU  - Martínez-Ramírez, María José
AU  - Del Castillo-Codes, Isabel
AU  - Arraiza-Irigoyen, Carmen
AU  - Tercero-Lozano, Mercedes
AU  - Camacho, José
AU  - Chueca, Natalia
AU  - García, Federico
AU  - Olza, Josune
AU  - Plaza-Díaz, Julio
AU  - Fontana, Luis
AU  - Olivares, Mónica
AU  - Gil, Ángel
AU  - Gómez-Llorente, Carolina
PY  - 2019
DO  - 10.3390/nu11081761
UR  - http://hdl.handle.net/10668/14352
T2  - Nutrients
AB  - Previous studies have reported that probiotics may improve clinical and inflammatory parameters in patients with obesity and metabolic syndrome (MetS). Lactobacillus (L.) reuteri V3401 has shown promising results on the components of MetS in animal...
LA  - en
KW  - Lactobacillus reuteri V3401
KW  - gastrointestinal microbiome
KW  - metabolic syndrome
KW  - obesity
KW  - probiotics
KW  - Adult
KW  - Biomarkers
KW  - Cross-Over Studies
KW  - Double-Blind Method
KW  - Female
KW  - Gastrointestinal Microbiome
KW  - Humans
KW  - Inflammation
KW  - Limosilactobacillus reuteri
KW  - Male
KW  - Metabolic Syndrome
KW  - Probiotics
TI  - Lactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study.
TY  - research article
VL  - 11
ER  -